Unilabs Selects Proscia’s AI For Skin Pathology

Proscia
By Author Proscia | September 15, 2022

Unilabs and Proscia have announced that the diagnostic group has chosen Proscia’s DermAI to advance its aspiration of becoming the most digitally-driven diagnostic group – enabling better decisions for a healthier tomorrow. The artificial intelligence-enabled technology will first be deployed in Sweden and then rolled out across other countries where Unilabs serves patients.

*DermAI is for research use only.

Our website uses cookies. By using this site, you agree to its use of cookies.